Most patients receive Lipo-Mino injections once a week, but some may benefit from twice-weekly treatments based on their goals and provider recommendations.
Medication availability (particularly brand-name Wegovy and Zepbound) may vary based on supply and regulatory factors
Ongoing research and clinical trials will continue to inform their safety profile, ensuring that healthcare providers can make informed decisions
OSA itself is a condition that causes repeated interruptions in breathing during sleep, often leading to poor sleep quality and daytime fatigue
Abed M, Thiel C, Towhid ST, Alzoubi K, Honisch S, Lang F, et al
J Clin Endocrinol Metab 63(2):492498